Albers J J, Marcovina S M, Kennedy H
Department of Medicine, University of Washington, Seattle 98103.
Clin Chem. 1992 May;38(5):658-62.
The first phase of an international collaborative study for standardization of test systems for measuring apolipoprotein (apo) A-I and apo B demonstrated that uniformity of apo A-I and apo B measurements can be achieved if suitable common reference materials are used to calibrate the different systems. The objective of the second phase was to evaluate the linearity and parallelism or proportionality of the candidate reference materials selected in phase one and to determine whether any of them could be proposed as international reference materials. We evaluated the proposed reference materials with 37 test systems for apo A-I and 38 for apo B, involving 23 manufacturers and five research laboratories. Two lyophilized preparations were proposed for apo A-I, SP1 from Behringwerke AG and SP2 from Daiichi Pure Chemicals Co., and two liquid preparations were proposed for apo B, SP3 from Behringwerke AG and SP4 from Reagents Applications. The linearity of the candidate reference materials was compared with the linearity of a frozen serum pool or interim serum reference material distributed to all the participants and with that of a fresh serum pool prepared by each participant. SP1 and SP3 exhibited linearity and parallelism similar to that of the fresh frozen serum pool and had among-laboratory CVs less than or similar to those obtained on normolipidemic serum samples (approximately 6% for apo A-I and approximately 7% for apo B).
一项用于测量载脂蛋白(apo)A-I和apo B的检测系统标准化的国际合作研究的第一阶段表明,如果使用合适的通用参考物质来校准不同系统,就能实现apo A-I和apo B测量的一致性。第二阶段的目标是评估在第一阶段选定的候选参考物质的线性度、平行度或比例关系,并确定其中是否有任何一种可以被提议作为国际参考物质。我们使用37种检测apo A-I的系统和38种检测apo B的系统对提议的参考物质进行了评估,涉及23家制造商和5个研究实验室。针对apo A-I提议了两种冻干制剂,即德国贝林公司的SP1和第一制药株式会社的SP2;针对apo B提议了两种液体制剂,即德国贝林公司的SP3和试剂应用公司的SP4。将候选参考物质的线性度与分发给所有参与者的冷冻血清混合样本或临时血清参考物质的线性度以及每个参与者制备的新鲜血清混合样本的线性度进行了比较。SP1和SP3表现出与新鲜冷冻血清混合样本相似的线性度和平行度,实验室间变异系数小于或类似于在血脂正常血清样本上获得的变异系数(apo A-I约为6%,apo B约为7%)。